Follow us on social media!
Upcoming Programs
Annual Events
Pharmacy Flash
AzPA Pharmacy Flash
- FDA Approves Neffy 1 MG Nasal Spray for Pediatric Patients March 12, 2025The FDA has approved ARS Pharmaceuticals' neffy 1mg for treating Type 1 allergic reactions in pediatric patients aged four and above. Neffy is the first significant innovation for this population in over 35 years, addressing the concern of 56% of caregivers about injecting their child.
- AI Augments Pharmacist Intelligence March 12, 2025Artificial intelligence is increasingly being integrated into clinical decision support systems in ICUs, aiding in decisions like dose optimization and enteral nutrition timing. AI is also being used in tele-critical care settings, where bedside pharmacists are unavailable, such as in rural hospitals.
- Ryoncil, the First FDA-Approved Mesenchymal Stromal Cell Therapy March 12, 2025Ryoncil, an allogeneic MSC therapy, is used to treat acute graft-versus-host disease in children, a common complication of alloHCT, with a high mortality rate and a need for a novel therapy.
Member Newsletter
AzPA sends out a bi-monthly member newsletter containing pertinent Arizona pharmacy news, industry updates, information on events and programs, and more!
AzPA Podcast Network
AzPA presents an innovative podcast intended for pharmacists and pharmacy technicians to obtain continuing education credit. The podcast also provides current health information and hot topics in the evolving world of pharmacy.
Career Center
Looking for a new career? Check out the career center for job postings or post your resume!